AKBM.OL Live signals | Maximize Profits with Getagraph.com

SELL 229 min ago

@ NOK73.00

Issued: 23 Apr 2024 @ 08:43

Return: 0.68%

Previous signal: Apr 23 - 05:52

Previous signal: Buy

Return: 0.00 %

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 10:25):
Our systems believe the stock currently is overvalued by 0.54% compare to its pairs and should correct downwards.

Stats
Today's Volume	23 508.00
Average Volume	47 201.00
Market Cap	6.44B
EPS	NOK0 ( 2024-02-13 )
Next earnings date	( NOK0 ) 2024-04-24
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	-66.82
ATR14	NOK4.20 (5.72%)

Correlation (AI algo v.1.1b): Overvalued: -0.54% NOK73.00 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.72 (moderate)

Short: 0.00 (neutral)

Signal:(98) Neutral

Aker BioMarine AS Correlation

10 Most Positive Correlations
PEN.OL	0.93
OKEA.OL	0.907
SBX.OL	0.87
NOL.OL	0.861
AKSO.OL	0.85
ZAL.OL	0.821
SHLF.OL	0.819
ODL.OL	0.819
ELK.OL	0.819
AIRX.OL	0.802

10 Most Negative Correlations
TOM.OL	-0.848
CADLR.OL	-0.826
KOMP.OL	-0.813
ATEA.OL	-0.81
HMONY.OL	-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aker BioMarine AS Correlation - Currency/Commodity

0.66
( moderate )

0.69
( moderate )

0.00
( neutral )

0.54
( weak )

-0.20
( neutral )

-0.15
( neutral )

Aker BioMarine AS Financials

Annual	2023
Revenue:	NOK335.30M
Gross Profit:	NOK112.90M (33.67 %)
EPS:	NOK0

Q4	2023
Revenue:	NOK82.90M
Gross Profit:	NOK26.80M (32.33 %)
EPS:	NOK0

Q3	2023
Revenue:	NOK94.60M
Gross Profit:	NOK35.20M (37.21 %)
EPS:	NOK0.0100

Q2	2023
Revenue:	NOK88.60M
Gross Profit:	NOK29.90M (33.75 %)
EPS:	NOK-0.0312

Financial Reports:

No articles found.

Aker BioMarine AS

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

Realtime updates for Aker BioMarine AS [AKBM.OL]

Upcoming Earnings Alert